Nanjing Hicin Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of June 2023: 0.08%

Nanjing Hicin Pharmaceutical Co Ltd (300584) has an Asset Resilience Ratio of 0.08% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300584 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.00 Million

≈ $146.40K USD Cash + Short-term Investments

Total Assets

CN¥1.32 Billion

≈ $193.31 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2020)

This chart shows how Nanjing Hicin Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Nanjing Hicin Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Nanjing Hicin Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300584 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.00 Million	0.08%
Total Liquid Assets	CN¥1.00 Million	0.08%

Asset Resilience Insights

Limited Liquidity: Nanjing Hicin Pharmaceutical Co Ltd maintains only 0.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Nanjing Hicin Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Nanjing Hicin Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
China SXT Pharmaceuticals Inc NASDAQ:SXTC	Drug Manufacturers - Specialty & Generic	0.64%
DHG Pharmaceutical JSC VN:DHG	Drug Manufacturers - Specialty & Generic	39.18%
Akanda Corp NASDAQ:AKAN	Drug Manufacturers - Specialty & Generic	-0.19%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Painreform Ltd NASDAQ:PRFX	Drug Manufacturers - Specialty & Generic	0.00%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	35.10%

Annual Asset Resilience Ratio for Nanjing Hicin Pharmaceutical Co Ltd (2017–2020)

The table below shows the annual Asset Resilience Ratio data for Nanjing Hicin Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	1.10%	CN¥10.00 Million ≈ $1.46 Million	CN¥906.52 Million ≈ $132.65 Million	-1.41pp
2018-12-31	2.52%	CN¥20.00 Million ≈ $2.93 Million	CN¥794.19 Million ≈ $116.21 Million	-16.62pp
2017-12-31	19.14%	CN¥121.00 Million ≈ $17.71 Million	CN¥632.30 Million ≈ $92.53 Million	--

pp = percentage points

About Nanjing Hicin Pharmaceutical Co Ltd

SHE:300584 China Drug Manufacturers - Specialty & Generic

Market Cap

$650.59 Million

CN¥4.45 Billion CNY

Market Cap Rank

#11293 Global

#3336 in China

Share Price

CN¥37.05

Change (1 day)

+1.23%

52-Week Range

CN¥27.90 - CN¥77.88

All Time High

CN¥83.16